216 related articles for article (PubMed ID: 34323190)
1. Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.
Gao M; Diao Q; Gao F; Sun X; Xiao J
Curr Top Med Chem; 2021; 21(18):1674-1691. PubMed ID: 34323190
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
3. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents.
Wen X; Zhou Y; Zeng J; Liu X
Curr Top Med Chem; 2020; 20(16):1441-1460. PubMed ID: 31994462
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes.
Elamari H; Slimi R; Chabot GG; Quentin L; Scherman D; Girard C
Eur J Med Chem; 2013 Feb; 60():360-4. PubMed ID: 23314049
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of New 1,2,3-Triazole Derivatives of the Chrysin Flavonoid as Anticancer Agents.
Noole V; Krishna T; Godeshala S; Meraji S; Rege K; Reddy CK; Kedika B
Anticancer Agents Med Chem; 2022; 22(1):160-168. PubMed ID: 33719963
[TBL] [Abstract][Full Text] [Related]
8. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
[TBL] [Abstract][Full Text] [Related]
12. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
[TBL] [Abstract][Full Text] [Related]
16. 5-alkylvinyl-1,2,4-triazole nucleosides: Synthesis and biological evaluation.
Prutkov AN; Chudinov MV; Matveev AV; Grebenkina LE; Akimov MG; Berezovskaya YV
Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):943-963. PubMed ID: 32126895
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Anticancer Activity of Triazole Linked Macrocycles and Heterocycles.
Srinivas A; Rao EK
Acta Chim Slov; 2021 Jun; 68(2):404-413. PubMed ID: 34738137
[TBL] [Abstract][Full Text] [Related]
18. Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review.
Kaur R; Dwivedi AR; Kumar B; Kumar V
Anticancer Agents Med Chem; 2016; 16(4):465-89. PubMed ID: 26286663
[TBL] [Abstract][Full Text] [Related]
19. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]